SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from JOHN HANCOCK LIFE INSURANCE CO (USA) SEPARATE ACCOUNT H (CIK 0000753892) — Sep 1, 2020

JOHN HANCOCK LIFE INSURANCE CO (USA) SEPARATE ACCOUNT H (CIK 0000753892)
Date: Sept. 1, 2020 · CIK: 0000753892 · Accession: 0001193125-20-236962

AI Filing Summary & Sentiment

File numbers found in text: 333-162245, 333-172473, 333-172476, 333-70728, 333-70850, 333-71072, 333-71074, 811-04113

Date
September 1, 2020
Author
Director
Form
CORRESP
Company
JOHN HANCOCK LIFE INSURANCE CO (USA) SEPARATE ACCOUNT H (CIK 0000753892)

Letter

VIA EDGAR Division of Investment Management Post-Effective Amendment No. 51 to the Registration Statement on Form N-4 of John Hancock Life Insurance Company (U.S.A.) Separate Account H File Nos. 333-70728, 811-04113

Re: Request for Template Filing Relief

Dear Ms. Magovern:

In accordance with Rule 485(b)(1)(vii) under the Securities Act of 1933, as amended (the “1933 Act”), John Hancock Life Insurance Company (U.S.A.) (“John Hancock”) respectfully requests template relief from the staff of the U.S. Securities and Exchange Commission with respect to Post-Effective Amendment No. 51 to the Registration Statement on Form N-4 of John Hancock Life Insurance Company (U.S.A.) Separate Account H (the “Registrant”) that was filed pursuant to Rule 485(a) on June 5, 2020 (the “Template Filing”). The Template Filing included a supplement that announces a limited offer to owners of certain variable annuity contracts, pursuant to which John Hancock would permit contract owners to voluntarily terminate their Income Plus For Life Series Riders and certain guaranteed death benefits (the “Offer Supplement”).

John Hancock proposes to use the Template Filing to include the Offer Supplement for the following post-effective amendments to be filed by the Registrant (the “Replicate Filings”). Because the Offer Supplement already covers each variable annuity contract to which the offer relates, John Hancock does not believe that any revisions to the Offer Supplement will be necessary for the Replicate Filings that are filed in reliance on the requested relief:

Replicate Filings

File Nos.

Relevant Contracts

(Contract Id Nos.)

Approximate Dates of

Filing and Effectiveness

Post-Effective Amendment No. 38

333-70850;

811-04113

Venture III (C000007846)

September 2, 2020

Post-Effective Amendment No. 37

333-71072;

811-04113

Vantage (C000007839)

September 2, 2020

Post-Effective Amendment No. 38

333-71074;

811-04113

Vision 2007 (C000043115)

Vis 25 (C000007837)

VV (C000007838)

September 2, 2020

Post-Effective Amendment No. 16

333-162245;

811-04113

Venture 4 (C000081726)

September 2, 2020

Post-Effective Amendment No. 11

333-172473;

811-04113

Venture 4 Series (C000100451)

September 2, 2020

Post-Effective Amendment No. 12

333-172476;

811-04113

Venture 7 Series (C000100454)

September 2, 2020

200 Berkeley Street, Boston, Massachusetts, United States, 02116

Andrea Ottomanelli Magovern, Assistant Director

September 1, 2020

Page 2

In connection with this request, John Hancock confirms that:

•

The disclosure changes in the Template Filing are substantially identical to the disclosure changes that will be made in the Replicate Filings; the Replicate Filings will be sufficiently identical to the Template Filing to make this request under Rule 485(b)(1)(vii) appropriate.

•

The Replicate Filings will incorporate changes made to the disclosure included in the Template Filing to resolve any SEC Staff comments thereon.

•

The Replicate Filings will not include any other changes that would otherwise render them ineligible for filing under Rule 485(b) under the 1933 Act.

* * * * *

We understand that the SEC Staff will respond orally to this request. Please direct your reply or any questions to me at 617-663-3192 or Sophia Pattas at 617-663-2332.

Very truly yours,
/s/ Thomas J. Loftus

Show Raw Text
CORRESP
1
filename1.htm

Request for Template Filing Relief

 VIA EDGAR

September 1, 2020

 Andrea Ottomanelli Magovern, Assistant
Director

 Division of Investment Management

 U.S. Securities
and Exchange Commission 100 F Street, N.E.

 Washington, D.C. 20549

Re:
 Request for Template Filing Relief

Post-Effective Amendment No. 51 to the Registration Statement on Form N-4 of

John Hancock Life Insurance Company (U.S.A.) Separate Account H

File Nos. 333-70728, 811-04113

Dear Ms. Magovern:

 In accordance with Rule 485(b)(1)(vii)
under the Securities Act of 1933, as amended (the “1933 Act”), John Hancock Life Insurance Company (U.S.A.) (“John Hancock”) respectfully requests template relief from the staff of the U.S. Securities and Exchange Commission with
respect to Post-Effective Amendment No. 51 to the Registration Statement on Form N-4 of John Hancock Life Insurance Company (U.S.A.) Separate Account H (the “Registrant”) that was filed pursuant
to Rule 485(a) on June 5, 2020 (the “Template Filing”). The Template Filing included a supplement that announces a limited offer to owners of certain variable annuity contracts, pursuant to which John Hancock would permit contract
owners to voluntarily terminate their Income Plus For Life Series Riders and certain guaranteed death benefits (the “Offer Supplement”).

 John
Hancock proposes to use the Template Filing to include the Offer Supplement for the following post-effective amendments to be filed by the Registrant (the “Replicate Filings”). Because the Offer Supplement already covers each variable
annuity contract to which the offer relates, John Hancock does not believe that any revisions to the Offer Supplement will be necessary for the Replicate Filings that are filed in reliance on the requested relief:

Replicate Filings

File Nos.

Relevant Contracts

(Contract Id Nos.)

Approximate Dates of

Filing and Effectiveness

Post-Effective
Amendment No. 38

 333-70850;

811-04113

Venture III (C000007846)

September 2, 2020

Post-Effective
Amendment No. 37

 333-71072;

811-04113

Vantage (C000007839)

September 2, 2020

Post-Effective
Amendment No. 38

 333-71074;

811-04113

 Vision 2007 (C000043115)

Vis 25 (C000007837)

 VV (C000007838)

September 2, 2020

Post-Effective
Amendment No. 16

 333-162245;

811-04113

Venture 4 (C000081726)

September 2, 2020

Post-Effective
Amendment No. 11

 333-172473;

811-04113

Venture 4 Series (C000100451)

September 2, 2020

Post-Effective
Amendment No. 12

 333-172476;

811-04113

Venture 7 Series (C000100454)

September 2, 2020

 200 Berkeley Street, Boston, Massachusetts, United States, 02116

 Andrea Ottomanelli Magovern, Assistant Director

September 1, 2020

 Page 2

In connection with this request, John Hancock confirms that:

•

 The disclosure changes in the Template Filing are substantially identical to the disclosure changes that will be
made in the Replicate Filings; the Replicate Filings will be sufficiently identical to the Template Filing to make this request under Rule 485(b)(1)(vii) appropriate.

•

 The Replicate Filings will incorporate changes made to the disclosure included in the Template Filing to resolve
any SEC Staff comments thereon.

•

 The Replicate Filings will not include any other changes that would otherwise render them ineligible for filing
under Rule 485(b) under the 1933 Act.

 * * * * *

We understand that the SEC Staff will respond orally to this request. Please direct your reply or any questions to me at 617-663-3192 or Sophia Pattas at 617-663-2332.

Very truly yours,

 /s/ Thomas J. Loftus

Thomas J. Loftus

 AVP and Assistant Chief Counsel

617-663-3192

tloftus@jhancock.com

200 Berkeley Street, Boston, Massachusetts, United States, 02116